Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | TDP2 | O95551 | 1/20 | 0.40 |
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.40 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | S100A4 | P26447 | 3/20 | 0.36 |
| ▸ | CDC25B | P30305 | 3/20 | 0.36 |
| ▸ | PTPRC | P08575 | 2/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13994697 | 0.77 | ALOX15 (0.33) | TDP1ALOX15 | |
| SCHEMBL311088 | 0.75 | TDP2 (0.58) | ALDH1A1TDP1MEN1KMT2ATDP2 | |
| SCHEMBL30694966 | 0.75 | TDP2 (0.58) | ALDH1A1TDP1MEN1KMT2ATDP2 | |
| SCHEMBL361673 | 0.72 | KDM4E (0.37) | TDP1KDM4E | |
| SCHEMBL4709728 | 0.71 | ALDH1A1 (0.36) | ALDH1A1TDP1MEN1KMT2ATDP2 | |
| SCHEMBL4076284 | 0.70 | NOS2 (0.38) | ALDH1A1TDP1MEN1KMT2ATDP2 | |
| SCHEMBL17159951 | 0.69 | ALDH1A1 (0.55) | ALDH1A1TDP1MEN1KMT2ATDP2 | |
| SCHEMBL2936414 | 0.67 | TDP1 (0.42) | ALDH1A1TDP1MEN1KMT2ATDP2 | |
| SCHEMBL14380284 | 0.67 | ALDH1A1 (0.36) | ALDH1A1TDP1MEN1KMT2ATDP2 | |
| SCHEMBL7719621 | 0.65 | S100A4 (0.54) | ALDH1A1TDP1MEN1KMT2ATDP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 644 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12620625-B2 | Electrolyte solution for lithium-ion battery and lithium-ion battery | BYD COMPANY LIMITED (CN) | 2026-05-05 | — | — | US | claimed |
| US-20260018671-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2026-01-15 | — | — | US | claimed |
| EP-4613796-A1 | STAR-SHAPED POLYMERS | Evonik Operations GmbH (DE) | 2025-09-10 | — | — | EP | claimed |
| CN-119757618-A | Detection method of eszopiclone intermediate YZ1 related substances | 江苏天士力帝益药业有限公司 | 2025-04-04 | — | — | CN | claimed |
| WO-2024192754-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | 宁德新能源科技有限公司 | 2024-09-26 | — | — | WO | claimed |
| CN-117820811-B | High-strength high-toughness easily-degradable epoxy resin composition, preparation method and application | 中国科学院宁波材料技术与工程研究所 | 2024-06-18 | — | — | CN | claimed |
| CN-118027608-A | Controllably degradable epoxy resin-based composite insulating material and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2024-05-14 | — | — | CN | claimed |
| CN-117903711-A | Blue insulating tape applied to lithium battery and manufacturing method thereof | 江西欣美新材料科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117866200-A | Polybenzoxazole precursor, process for producing the same, and photosensitive resin composition | 上海交通大学 | 2024-04-12 | — | — | CN | claimed |
| CN-117820811-A | High-strength high-toughness easily-degradable epoxy resin composition, preparation method and application | 中国科学院宁波材料技术与工程研究所 | 2024-04-05 | — | — | CN | claimed |
| EP-2423215-A1 | PRODRUGS BASED ON GEMCITABINE STRUCTURE AS WELL AS SYNTHETIC METHOD AND APPLICATION THEREOF | Sanlugen Pharmatech Ltd. (CN) | 2012-02-29 | — | — | EP | claimed |
| CN-102115485-A | Prodrug based on cytosine arabinoside structure, and synthesis method and application thereof | SANLUGEN PHARMATECH | 2011-07-06 | — | — | CN | claimed |
| CN-101525361-B | Prodrug based on gemcitabine structure as well as synthesizing method and application thereof | JINAN SHENGLUJIN PHARMACEUTICAL TECHNOLOGY DEV CO LTD | 2010-11-17 | — | — | CN | claimed |
| US-7786304-B2 | Process for the preparation of eszopiclone | CENTAUR PHARMACEUTICAL PVT. LTD. (IN) | 2010-08-31 | — | — | US | claimed |
| CN-101525361-A | Prodrug based on gemcitabine structure as well as synthesizing method and application thereof | SANLUGEN PHARMATECH DEV CO LTD | 2009-09-09 | — | — | CN | claimed |
| EP-1725604-B1 | CARBOXYLIC ACID COMPOUNDS COMPRISING ESTER BONDS AND POLYAMIDES PRODUCED THEREFROM | LANXESS DEUTSCHLAND GMBH (DE) | 2009-04-29 | — | — | EP | claimed |
| US-20080146800-A1 | Process for the preparation of eszopiclone | CENTAUR PHARMACEUTICAL PVT. LTD. (IN) | 2008-06-19 | — | — | US | claimed |
| US-5532328-A | Process for the preparation of a polymer | DSM N.V. (NL) | 1996-07-02 | — | — | US | claimed |
| EP-0633903-A1 | PROCESS FOR THE PREPARATION OF A POLYMER FROM A HETEROCYCLIC MONOMER | DSM N.V. (NL) | 1995-01-18 | — | — | EP | claimed |
| WO-1994017120-A1 | PROCESS FOR THE PREPARATION OF A POLYMER FROM A HETEROCYCLIC MONOMER | DSM N.V. (NL) | 1994-08-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080146800-A1 | Process for the preparation of eszopiclone | CYP3A5, CYP3A7, CYP51A1 | ALDH1A1 1055/4885TDP1 4701/4885MEN1 4427/4885 |
| US-20260018671-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | CACNA2D3, VMP1, CACNA2D2 | ALDH1A1 3909/4885TDP1 2793/4885MEN1 1649/4885 |
| US-12620625-B2 | Electrolyte solution for lithium-ion battery and lithium-ion battery | SLC9A1, HCN4, HCN1 | ALDH1A1 1408/4885TDP1 2628/4885MEN1 3961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.